Seeking Alpha

The M & A Researcher » Articles » EXAR |

More on EXAR by The M & A Researcher

Latest Comments on The M & A Researcher's Articles

  1. JAXX on Barring Legal Issues Sallie Mae Buyout Projected For September : AFS Holdings LLC, Arrow Financial Services LLC are scumbags and... more »
  2. daveddawg on Will Terra Industries Reverse Its Position on CF Industries?: The author didn't even get the stock symbol correct. It is AGU,... more »
  3. mangy cat on Will Terra Industries Reverse Its Position on CF Industries?: looks like the classic organic fertilizer hit the fan for agu today more »
  4. Bruschak on Pfizer - Wyeth Merger Looks to Be Clear of Antitrust Concerns: What is the conclusion of this article (No anti-trust issues in... more »
  5. Irony? on Pfizer - Wyeth Merger Looks to Be Clear of Antitrust Concerns: Taxpayers money bails out banks. Banks then fund PFE. PFE uses... more »
  6. Soon to be Unemployed on Pfizer - Wyeth Merger Looks to Be Clear of Antitrust Concerns: How many pharmaceutical companies does Pfizer have to destroy... more »
  7. TnTMom on Pfizer - Wyeth Merger Looks to Be Clear of Antitrust Concerns: The FTC should kill this deal simply on the grounds that Pfizer is... more »
  8. User 354250 on Have Pfizer and Wyeth Considered Their Competing Products?: You could not be more incorrect in your claim that Enbrel and... more »
  9. Pharma employee on Will Pfizer - Wyeth Product Overlap Present Antitrust Problems?: M & A "Researcher" ????? Zoloft close to 20%?????? ...Now I know... more »
  10. User 342958 on Will Pfizer - Wyeth Product Overlap Present Antitrust Problems?: See also animal health. more »
  11. ZiggaZagga on Will Pfizer - Wyeth Product Overlap Present Antitrust Problems?: Do your homework M & A Researcher.... or better still, get someone... more »
  12. donzelion on Will Pfizer - Wyeth Product Overlap Present Antitrust Problems?: Patent issues raise problematic concerns when they interact with... more »
  13. Scott Hinds on Will Pfizer - Wyeth Product Overlap Present Antitrust Problems?: Zoloft went off patent in 2006, and currently has a market share... more »
  14. Dan Jacome on Indevus / Endo Pharmaceuticals Merger Looks Good to Go: ENDP has a history of using acquisitions to grow, since their... more »
  15. CrossProfit_ on DRS Update: The Company's Acquisition Could Be Sensitive: @real M&A hound, Not a bad guess for the closing date. Based on... more »